BetterLife Pharma Inc.

Overview

Compare with another stock.

• TickerBETRF on OTC¹
• IndustryPharmaceutical Preparations¹
• HeadquartersVancouver, Canada¹
• Incorporated inBritish Columbia, Canada³
• Business address1275 West 6Th Avenue, Vancouver, A1 V6H 1A6³
• Filer categoryNon-accelerated filer³

See how the biggest companies compare on our leaderboards

We are a publicly traded corporation incorporated on June 10, 2002 in the province of British Columbia, Canada under the name “649186 B.C. Ltd.”. On September 9, 2003, we changed our name to “Xerxes Health Corp.”. On June 26, 2007, we changed our name to “Neurokine Pharmaceuticals Inc.”. On April 7, 2015, we changed our name to “Pivot Pharmaceuticals Inc.” and on December 5, 2019, we changed our name to “BetterLife Pharma Inc.”.⁴ From its latest annual report

Corporate structure

BetterLife Pharma Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Who has led BetterLife Pharma Inc., and when. Pick a name to see everywhere that person has worked.

• ChairAhmad Doroudian Mar 10, 2015 to Mar 10, 2015¹²
• PresidentBarbara-Jean Anne Bormann-Kennedy Mar 3, 2015 to Mar 3, 2015¹³
• Chief financial officerMoira Ong Mar 3, 2015 to Mar 3, 2015¹⁴

Former names

• Pivot Pharmaceuticals Inc.Apr 17, 2015 to Dec 3, 2019³
• Neurokine Pharmaceuticals Inc.Aug 7, 2009 to Mar 26, 2015³

Filings

71 filings to the SEC since October 2021: 6 annual reports, 1 large holders, 64 other. The latest 20:

1. Sep 30, 20266-K EDGAR
2. Sep 22, 2026SCHEDULE 13G EDGAR
3. Sep 15, 20266-K EDGAR
4. Sep 11, 20266-K EDGAR
5. Aug 24, 20266-K EDGAR
6. Aug 5, 20266-K EDGAR
7. Jun 26, 20266-K EDGAR
8. Jun 25, 20266-K EDGAR
9. Jun 1, 202620-F EDGAR
10. Apr 13, 20266-K EDGAR
11. Sep 29, 20256-K EDGAR
12. Jul 28, 20256-K EDGAR
13. Jun 27, 20256-K EDGAR
14. Jun 23, 20256-K EDGAR
15. Jun 2, 202520-F EDGAR
16. May 30, 20256-K EDGAR
17. May 7, 20256-K EDGAR
18. Apr 7, 20256-K EDGAR
19. Dec 31, 20246-K EDGAR
20. Dec 9, 20246-K EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• RA CAPITAL MANAGEMENT, L.P.SCHEDULE 13G, 1 filing Sep 22, 2026¹⁶

SEC filer profile

How BetterLife Pharma Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARBetterLife Pharma Inc.¹
• CIK0001464165
• Filer statusNon-accelerated filer not an emerging growth company; not a shell company⁴
• Incorporated inCanada⁴
• Fiscal year endsJanuary 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address1275 West 6Th Avenue, Vancouver, A1 V6H 1A6¹
• Phone438-884-8841¹
• Shares outstanding151,896,675 shares as of Jun 1, 2026⁴
• On EDGAR sinceAug 7, 2009¹
• Filings244 in all: 6-K (111), 10-Q (28), 8-K (26), 10-K (10), 20-F (7), NT 10-K (7), NT 10-Q (7), UPLOAD (7)¹
  All 25 form types

  CORRESP (5), DEF 14A (5), 20-F/A (4), 3 (4), 10-K/A (3), 8-K/A (3), S-1/A (3), 5 (2), DEFR14A (2), NT 20-F (2), PRE 14A (2), 10-Q/A (1), 6-K/A (1), D (1), EFFECT (1), S-1 (1), SCHEDULE 13G (1)

• Latest filingsAnnual report (20-F) Jun 1, 2026
  Quarterly report (10-Q) Jun 17, 2019
  Proxy statement (DEF 14A) Feb 19, 2019
  Latest 8-K (8-K) May 21, 2019

Securities registered for trading

From the cover page of the 20-F filed Jun 1, 2026 (Section 12(b) of the Exchange Act).⁴